相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and Molecular Docking Study
Edgar Marquez et al.
MOLECULES (2020)
Novel 11-Substituted Ellipticines as Potent Anticancer Agents with Divergent Activity against Cancer Cells
Charlotte M. Miller et al.
PHARMACEUTICALS (2019)
Synthesis and Activity against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives
Ulrike Schmidt et al.
MOLECULES (2018)
ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer
Shuixiang Tao et al.
MOLECULAR MEDICINE REPORTS (2017)
Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
Benny Zhitomirsky et al.
ONCOTARGET (2017)
Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage
Cecilia Savorani et al.
LEUKEMIA & LYMPHOMA (2015)
Ellipticine derivative induces potent cytostatic effect in acute myeloid leukaemia cells
E. G. Russell et al.
INVESTIGATIONAL NEW DRUGS (2014)
Total Synthesis of Ellipticine Quinones, Olivacine, and Calothrixin B
Nagarajan Ramkumar et al.
JOURNAL OF ORGANIC CHEMISTRY (2014)
Imaging exocytosis of ATP-containing vesicles with TIRF microscopy in lung epithelial A549 cells
Irina Akopova et al.
PURINERGIC SIGNALLING (2012)
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways
Michela Palmieri et al.
HUMAN MOLECULAR GENETICS (2011)
Ellipticine induces apoptosis in human endometrial cancer cells: The potential involvement of reactive oxygen species and mitogen-activated protein kinases
Ji Young Kim et al.
TOXICOLOGY (2011)
Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer
M. Loddo et al.
BRITISH JOURNAL OF CANCER (2009)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
The mechanism of ellipticine-induced apoptosis and cell cycle arrest in human breast MCF-7 cancer cells
PL Kuo et al.
CANCER LETTERS (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling
M Stiborová et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Rescue of mutant p53 transcription function by ellipticine
YH Peng et al.
ONCOGENE (2003)
Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules
A Awada et al.
ANNALS OF ONCOLOGY (2002)
Diverse effects of 9-hydroxyellipticine on the chemosensitivity of human pancreatic cancer cells harboring p53 mutations
K Mizumoto et al.
CANCER LETTERS (2000)